BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1309 related articles for article (PubMed ID: 9675540)

  • 1. Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans.
    Olsen NV
    Dan Med Bull; 1998 Jun; 45(3):282-97. PubMed ID: 9675540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
    Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
    Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine natriuresis in salt-repleted, water-loaded humans: a dose-response study.
    Olsen NV; Olsen MH; Bonde J; Kanstrup IL; Plum I; Strandgaard S; Leyssac PP
    Br J Clin Pharmacol; 1997 May; 43(5):509-20. PubMed ID: 9159566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of fenoldopam on renal haemodynamics and natriuresis in chronic renal failure.
    de Fijter CW; Comans EF; de Vries PM; Oe PL; Roos JC; Smit AJ; Streurman O; Donker AJ
    Neth J Med; 1990 Jun; 36(5-6):267-78. PubMed ID: 1975651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparing studies on the influence of dopamine and orciprenaline on cardiac and renal function of patients after cardiac surgery (author's transl)].
    Nadjmabadi MH; Purschke R; Tarbiat S; Lennartz H; Bircks W
    Thoraxchir Vask Chir; 1975 Dec; 23(6):552-9. PubMed ID: 1082662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence from functional and autoradiographic studies for the presence of tubular dopamine-1 receptors and their involvement in the renal effects of fenoldopam.
    Hedge SS; Ricci A; Amenta F; Lokhandwala MF
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1237-45. PubMed ID: 2574743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H; Nielsen CB; Pedersen EB
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of low-dose dopamine on kidney function and vasoactive hormones in pediatric patients with advanced renal failure.
    Tulassay T; Rascher W; Schärer K
    Clin Nephrol; 1987 Jul; 28(1):22-7. PubMed ID: 3621687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].
    De Vecchis R; Pucciarelli G; Nocerino L; Cocozza M; Setaro A; Torre G; Imperatore F
    Minerva Cardioangiol; 1998 May; 46(5):163-74. PubMed ID: 9842199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The mechanism of the natriuretic action of dopamine in the anesthetized dogs (author's transl)].
    Schmidt M; Imbs JL; Schwartz J
    J Pharmacol; 1981; 12(1):59-71. PubMed ID: 7218817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
    Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
    J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An effect of extrarenal beta adrenergic stimulation on the release of renin.
    Reid IA; Schrier RW; Earley LE
    J Clin Invest; 1972 Jul; 51(7):1861-9. PubMed ID: 4402350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of selective dopamine receptor subtype agonists on cardiac contractility and regional haemodynamics in rats.
    Polakowski JS; Segreti JA; Cox BF; Hsieh GC; Kolasa T; Moreland RB; Brioni JD
    Clin Exp Pharmacol Physiol; 2004 Dec; 31(12):837-41. PubMed ID: 15659045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New inotropic agents in the treatment of congestive heart failure].
    Freitas M
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine, dobutamine, and dopexamine. A comparison of renal effects in unanesthetized human volunteers.
    Olsen NV; Lund J; Jensen PF; Espersen K; Kanstrup IL; Plum I; Leyssac PP
    Anesthesiology; 1993 Oct; 79(4):685-94. PubMed ID: 8105728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divergent natriuretic action of calcium channel antagonists in mongrel dogs: renal haemodynamics as a determinant of natriuresis.
    Honda M; Hayashi K; Matsuda H; Kubota E; Tokuyama H; Okubo K; Ozawa Y; Saruta T
    Clin Sci (Lond); 2001 Oct; 101(4):421-7. PubMed ID: 11566080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actions of adrenergic and cholinergic drugs on renal tubular cells.
    Garg LC
    Pharmacol Rev; 1992 Mar; 44(1):81-102. PubMed ID: 1557426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dependence of saline-induced natriuresis upon exposure of the kidney to the physical effects of extracellular fluid volume expansion.
    Fitzgibbons JP; Gennari FJ; Garfinkel HB; Cortell S
    J Clin Invest; 1974 Dec; 54(6):1428-36. PubMed ID: 4436441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon and the circulation.
    Farah AE
    Pharmacol Rev; 1983 Sep; 35(3):181-217. PubMed ID: 6318231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.